Studies In Italy Offer New Evidence of HCQ Role in Saving Lives

 https://yated.com/studies-in-italy-offer-new-evidence-of-hcq-role-in-saving-lives/

 A wave of new evidence from studies in Italy, Belgium and the United States showing the effectiveness of hydroxychloroquine (HCQ) in reducing death from Covid-19, is spiking public demand for the drug even as the FDA continues to block its release and Americans die.

The following events bear out Dr. Atlas’ grim assessment. On August 10, ignoring the wealth of new HCQ-supporting data coming out of studies in Italy, Belgium and New Jersey, the FDA denied Henry Ford Hospital’s urgent request for emergency use approval (EUA) for HCQ.

The Hospital made the request after its clinical trials found an impressive 51% reduction in deaths if HCQ was begun within 24 hours of admission to hospital. These findings were supported by studies led by Dr. Peter McCullough’s team from Balyor Cardiac and Vascular Hospital in Dallas. The Baylor data showed prophylactic benefits of HCQ given to hospital workers who were exposed daily to Covid during the course of their work.